Canada markets closed

Axsome Therapeutics, Inc. (AXSM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
67.90+2.18 (+3.32%)
At close: 04:00PM EDT
67.77 -0.13 (-0.19%)
After hours: 06:09PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.11B
Enterprise Value 2.91B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)11.04
Price/Book (mrq)16.31
Enterprise Value/Revenue 10.77
Enterprise Value/EBITDA -12.95

Trading Information

Stock Price History

Beta (5Y Monthly) 1.10
52-Week Change 3-7.39%
S&P500 52-Week Change 320.07%
52 Week High 398.40
52 Week Low 355.02
50-Day Moving Average 377.91
200-Day Moving Average 374.82

Share Statistics

Avg Vol (3 month) 3734.94k
Avg Vol (10 day) 3594.33k
Shares Outstanding 547.37M
Implied Shares Outstanding 647.37M
Float 834.88M
% Held by Insiders 117.12%
% Held by Institutions 183.49%
Shares Short (Mar 28, 2024) 47.65M
Short Ratio (Mar 28, 2024) 48.86
Short % of Float (Mar 28, 2024) 419.44%
Short % of Shares Outstanding (Mar 28, 2024) 416.15%
Shares Short (prior month Feb 29, 2024) 47.47M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -88.41%
Operating Margin (ttm)-77.68%

Management Effectiveness

Return on Assets (ttm)-24.86%
Return on Equity (ttm)-159.21%

Income Statement

Revenue (ttm)270.6M
Revenue Per Share (ttm)5.96
Quarterly Revenue Growth (yoy)193.50%
Gross Profit (ttm)N/A
EBITDA -182.45M
Net Income Avi to Common (ttm)-239.24M
Diluted EPS (ttm)-5.27
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)386.19M
Total Cash Per Share (mrq)8.15
Total Debt (mrq)186.37M
Total Debt/Equity (mrq)97.59%
Current Ratio (mrq)3.63
Book Value Per Share (mrq)4.03

Cash Flow Statement

Operating Cash Flow (ttm)-145.08M
Levered Free Cash Flow (ttm)-78.72M